From what I see, SGC shares have traded in a relatively contained range through the second half of 2026. The stock sat near $13.86 in mid-November after recovering from roughly $12.63 about a month earlier — a gain of approximately 9.7%. The move reflects steady, if mixed, operational results rather than a single dramatic catalyst. Broader sentiment has been supported by continued revenue growth in the Branded Products and Contact Centers segments, tempered by an ongoing repositioning in Healthcare Apparel that has pressured near-term profitability. With a modest market capitalization and a regular dividend, SGC tends to attract investors focused on cash flow, diversification, and income rather than high-growth momentum.
Founded in 1920 and headquartered in St. Petersburg, Florida, Superior Group of Companies is a diversified provider of branded merchandise and business services. Its Branded Products segment designs, manufactures, and distributes uniforms, workwear, and promotional apparel and accessories for a wide range of corporate and institutional customers. The Healthcare Apparel segment supplies scrubs and related medical uniforms, while the Contact Centers segment — operating as The Office Gurus — provides business-process outsourcing, customer support, and back-office services across onshore, nearshore, and, following a recent acquisition, offshore locations. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investors follow SGC for its multi-segment diversification, which helps offset cyclicality in any single end market, as well as for its long history of shareholder returns. The company has delivered a consolidated revenue compound annual growth rate of about 7% from 2019 through 2025 and has maintained an uninterrupted dividend record stretching back decades. Competitive strengths include high customer retention across its segments, established brand relationships in the uniform market, and a growing global delivery footprint in contact-center services.
The most significant recent development was the company's third-quarter 2026 report, released in early November. Total net sales rose to $146 million, up 5% year over year, with Branded Products revenue reaching $92 million (+8%) and Contact Centers revenue reaching $24 million (+7%). Branded Products EBITDA grew 31% and Contact Centers EBITDA rose 22%, supported by higher volumes, new customer additions, and improved margins. Healthcare Apparel, by contrast, saw revenue decline 3% to $31 million, with a roughly $4 million inventory write-down and an approximately $1 million credit loss tied to a customer's financial position weighing on segment profitability.
Management also announced the acquisition of Select VoiceCom, a Philippines-based business-process outsourcing provider generating approximately $20 million in annual revenue, for about $27 million in upfront cash plus an earnout. The transaction expands The Office Gurus into offshore delivery and is expected to be accretive to earnings beginning in the first quarter of 2027. On the balance sheet, SGC reported $28 million in cash at quarter-end and $31 million in year-to-date operating cash flow, and it amended and extended its $200 million senior secured credit facility to 2031. The company tightened its 2026 outlook, raising the low end of both sales and adjusted EPS guidance.
Looking ahead, investors should monitor the progress of the Healthcare Apparel assortment reset, since management has signaled continued margin pressure into the first half of 2027 as inventory is discounted to streamline the product line. The integration of Select VoiceCom and its expected earnings accretion in early 2027 will also be a key focus. Full-year 2026 guidance now calls for net sales of $578–$585 million and adjusted diluted EPS of $0.60–$0.66, up from $0.46 in 2025. Macroeconomic factors — including potential tariff and political changes heading into 2027 — remain a source of uncertainty management has acknowledged, though the company has indicated it does not anticipate drastic impacts. Competitive dynamics in healthcare apparel and demand trends across corporate uniform and customer-support markets will continue to shape results.
One tool I find useful for monitoring names like SGC is Tickeron’s AI Trading Bots. It provides a range of algorithmic strategies that can be compared across different market conditions, helping me evaluate positioning in real time without replacing my own analysis. The platform draws from hundreds of bots monitoring thousands of tickers, offering a practical way to cross-check signals on diversified holdings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SGC moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SGC as a result. In 88 of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for SGC just turned positive on November 04, 2026. Looking at past instances where SGC's MACD turned positive, the stock continued to rise in 40 of 53 cases over the following month. The odds of a continued upward trend are 75%.
Following a +6.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGC advanced for three days, in 191 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 168 of 209 cases where SGC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
SGC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. SGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.108) is normal, around the industry mean (2.911). P/E Ratio (24.000) is within average values for comparable stocks, (14.016). Projected Growth (PEG Ratio) (1.418) is also within normal values, averaging (0.686). Dividend Yield (0.042) settles around the average of (0.328) among similar stocks. P/S Ratio (0.326) is also within normal values, averaging (0.827).
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of employee uniforms, image apparel, scrubs and patient apparel
Industry ApparelFootwear